Characterization of Diet1, a hypercholesterolemia resistance gene
Characterization of Diet1, a hypercholesterolemia resistance gene
批准号:
8213725
负责人:
Karen Reue
金额:
$38.12万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2014-01-31
关键词:
AccountingAdipocytesAlgorithmsAmino Acid SequenceAtherogenic DietAtherosclerosisBile Acid Biosynthesis PathwayBile AcidsBiochemicalBiological AssayBloodC57BL/6 MouseCandidate Disease GeneCholesterolCholesterol HomeostasisCholic AcidsChromosomes, Human, Pair 2CodeDNA ResequencingDietDiseaseEatingEmployee StrikesEnergy MetabolismEpithelial CellsExcretory functionExhibitsExonsFGF21 geneFatty AcidsFibroblast Growth FactorGene ExpressionGene ProteinsGenesGeneticGenetic VariationGenotypeHaplotypesHepaticHigh Density LipoproteinsHumanHuman GenomeIn VitroInbred StrainInbred Strains MiceIndividualIntestinesLDL Cholesterol LipoproteinsLeadLesionLiverLow Density Lipoprotein ReceptorLow-Density LipoproteinsMapsMediatingMolecularMusMutationNucleotidesPathway interactionsPeptide Sequence DeterminationPhenotypePhysiologicalPolymorphic Microsatellite MarkerPopulationProteinsRegulationResistanceRiskRoleSamplingSecondary toSignal TransductionSmall IntestinesSystemTertiary Protein StructureTestingThermogenesisTransgenic MiceVariantWild Type Mousebasecardiovascular disorder riskenergy balancefeedinggenetic variantgenome sequencinghypercholesterolemiain vivolipid metabolismlipid transportmouse genomemouse modelnovelnull mutationpopulation basedpositional cloningprotein functionpublic health relevanceresponsetrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Elevated levels of total and low-density lipoprotein (LDL) cholesterol are associated with increased risk for atherosclerosis. Individuals within the human population exhibit a large range of cholesterol levels, likely determined by the interplay between environmental and genetic factors. Currently known genetic variations account for only a fraction of the total variance of cholesterol levels, suggesting that novel pathways and genes remain to be identified. Using positional cloning, we have identified the Diet1 gene from an inbred mouse strain that is resistant to diet-induced hypercholesterolemia and atherosclerosis. Diet1 encodes a novel protein characterized by repeating MAM and LDL receptor type A domains, and is expressed predominantly in the small intestine. The Diet1 protein sequence is highly conserved between mouse and humans. We therefore hypothesize that the human DIET1 gene is an excellent candidate gene for effects on cholesterol levels and related traits in humans. We propose to characterize Diet1 function at the molecular, cellular and physiological levels. The specific aims are: (1) Determine the cellular role of Diet1 in lipid metabolism. Our studies indicate that Diet1 is expressed in the small intestinal epithelial cells, and we hypothesize that it functions in intracellular bile acid transport. We will determine the cellular compartment(s) in which Diet1 functions, characterize the potential role of Diet1 in cellular lipid transport, and investigate the regulation of DIET1 gene expression. (2) Determine the physiological role of Diet1 in the regulation of cholesterol homeostasis. Diet1 deficient mice exhibit enhanced bile acid excretion, increased bile acid synthesis, and impaired induction of fibroblast growth factor 15 (FGF15), a key intestinal signal for the regulation of hepatic bile acid synthesis. We will test the hypothesis that the alterations in cholesterol homeostasis in Diet1 deficient mice can be attributed to impaired FGF15 regulation by FGF15 replacement in vivo. We will also determine whether enhanced Diet1 expression leads to altered enterohepatic signaling or altered cholesterol homeostasis using a Diet1 transgenic mouse. (3) Determine the mechanism underlying enhanced adaptive thermogenesis in Diet1 deficient mice. Diet1 deficient mice exhibit enhanced basal energy expenditure and adaptive thermogenesis. We hypothesize that increased circulating bile acid levels resulting from Diet1 deficiency stimulate increased fatty acid fuel availability mediated by effects on FGF21. We will test this mechanism by studies in isolated brown adipocytes, and by FGF21 administration in wild-type mice. (4) Identify common and rare variants in human DIET1 and determine association with cholesterol levels. We hypothesize that common or rare DIET1 genetic variants influence cholesterol levels in the human population. We will resequence the DIET1 coding exons from individuals with extreme high and low bile acid and LDL-C levels in a population-based sample of 8000 individuals. We will identify common and rare variants that lead to potential changes in protein function, and test these using functional assays.
PUBLIC HEALTH RELEVANCE: We have identified a mutation in a novel gene-Diet1-that confers resistance to high blood cholesterol levels and atherosclerosis in the mouse. Here we will determine how Diet1 functions in the intestine to regulate bile acid synthesis and cholesterol levels using mouse models, and will investigate whether sequence variations in the human Diet1 gene influence cholesterol levels and cardiovascular disease risk in the human population. Results will further elucidate the mechanisms that control cholesterol homeostasis, and may suggest new strategies for protection or treatment of hypercholesterolemia and related disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex Differences in Postprandial Lipid Metabolism
-
批准号:10667618
-
项目类别:
-
资助金额:$44.93万
-
财政年份:2022
-
负责人:Karen Reue
-
依托单位:
Sex Differences in Postprandial Lipid Metabolism
-
批准号:10540166
-
项目类别:
-
资助金额:$44.93万
-
财政年份:2022
-
负责人:Karen Reue
-
依托单位:
A novel gene and mechanisms for statin-induced myopathy in the mouse
-
批准号:10265483
-
项目类别:
-
资助金额:$16.65万
-
财政年份:2020
-
负责人:Karen Reue
-
依托单位:
A novel gene and mechanisms for statin-induced myopathy in the mouse
-
批准号:10041615
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2020
-
负责人:Karen Reue
-
依托单位:
Leadership Administration Core
-
批准号:10713761
-
项目类别:
-
资助金额:$10.84万
-
财政年份:2018
-
负责人:Karen Reue
-
依托单位:
Sex Differences in the Metabolic Syndrome
-
批准号:10225900
-
项目类别:
-
资助金额:$152.02万
-
财政年份:2018
-
负责人:Karen Reue
-
依托单位:
Sex Differences in the Metabolic Syndrome
-
批准号:9788442
-
项目类别:
-
资助金额:$152.02万
-
财政年份:2018
-
负责人:Karen Reue
-
依托单位:
Epigenetic sex determinants of cardiometabolic disease and prevention
-
批准号:10713758
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2018
-
负责人:Karen Reue
-
依托单位:
Sex Differences in Cardiometabolic Health and Disease
-
批准号:10713757
-
项目类别:
-
资助金额:$149.76万
-
财政年份:2018
-
负责人:Karen Reue
-
依托单位:
Sex Differences in the Metabolic Syndrome
-
批准号:10447051
-
项目类别:
-
资助金额:$152.02万
-
财政年份:2018
-
负责人:Karen Reue
-
依托单位:
Sex Differences in the Metabolic Syndrome
-
批准号:10004046
-
项目类别:
-
资助金额:$152.02万
-
财政年份:2018
-
负责人:Karen Reue
-
依托单位:
Characterization of Diet1, a hypercholesterolemia resistance gene
-
批准号:8423074
-
项目类别:
-
资助金额:$36.29万
-
财政年份:2010
-
负责人:Karen Reue
-
依托单位:
Characterization of Diet1, a hypercholesterolemia resistance gene
-
批准号:7862232
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2010
-
负责人:Karen Reue
-
依托单位:
XF24-3 Extracellular Flux Analyzer
-
批准号:7793965
-
项目类别:
-
资助金额:$16.78万
-
财政年份:2010
-
负责人:Karen Reue
-
依托单位:
Lipid Droplets: Metabolic Consequences of the Storage of Neutral Lipids
-
批准号:8005259
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2010
-
负责人:Karen Reue
-
依托单位:
Characterization of Diet1, a hypercholesterolemia resistance gene
-
批准号:8062292
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2010
-
负责人:Karen Reue
-
依托单位:
Lipid Storage and the Metablic Syndrome
-
批准号:8001177
-
项目类别:
-
资助金额:$43.13万
-
财政年份:2010
-
负责人:Karen Reue
-
依托单位:
The Lipid Protein Family and Triglyceride Metabolism
-
批准号:7898772
-
项目类别:
-
资助金额:$47.24万
-
财政年份:2009
-
负责人:Karen Reue
-
依托单位:
The Lipin Protein Family and Triglyceride Metabolism
-
批准号:8608034
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2008
-
负责人:Karen Reue
-
依托单位:
The Lipid Protein Family and Triglyceride Metabolism
-
批准号:7537502
-
项目类别:
-
资助金额:$55.81万
-
财政年份:2008
-
负责人:Karen Reue
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: